| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |